Renan Jin

Sir Run Run Shaw Hospital — China

Medicine · Health Sciences

18h-index1.8kcitations54works2.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(13), Cholangiocarcinoma and Gallbladder Cancer Studies(10), Cancer Mechanisms and Therapy(7), Cancer Immunotherapy and Biomarkers(6), Immune Cell Function and Interaction(6)

Publications54 total

Arbitrarily Shapeable Couplant with Fluidity Onset for Conformal Ultrasound
Advanced Materials·2025· 2 cited
Planning and Compliant Control for Laparoscopic Ultrasound Scanning System
IEEE Robotics and Automation Letters·2025
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy
European Journal of Surgical Oncology·2025· 1 cited
[A preliminary exploration of clinical practice in 5G-ultra-long-distance robot-assisted liver resection].
PubMed·2025
Minimally invasive versus open liver resection for hepatocellular carcinoma with microvascular invasion: a propensity score-matching study
Surgical Endoscopy·2025· 1 cited
Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study
Liver Cancer·2025· 3 citedOpen Access
[Clinical practice of minimally invasive daytime hepatectomy based on enhanced recovery after surgery whole-process management scheme].
PubMed·2025· 1 cited
Correction: TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression
Cell Death and Disease·2025Open Access
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth
Molecular Cell·2025· 17 citedOpen Access
Force control for the robot-assisted laparoscopic ultrasound scanning system
Sensors and Actuators A Physical·2024Open Access
Screening of PDSS1 as a potential biomarker for hepatocellular carcinoma based on a copper-related prognostic signature through bulk and single-cell RNA-sequencing analysis
Research Square (Research Square)·2024Open Access
Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.
Journal of Clinical Oncology·2024· 2 cited
Screening of PDSS1 as a Potential Biomarker for Hepatocellular Carcinoma Based on a Copper-Related Prognostic Signature through Bulk and Single-cell RNA-sequencing Analysis
Journal of Cancer·2024· 1 citedOpen Access
Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study
The Oncologist·2023· 13 citedOpen Access
Erratum to “Research trends in cholangiocarcinoma treatments during the last 3 decades” [Heliyon 9(7) (July 2023) e17100]
Heliyon·2023Open Access
Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma
Hepatology International·2023· 10 citedOpen Access
Research trends in cholangiocarcinoma treatments during the last 3 decades
Heliyon·2023· 1 citedOpen Access
Robot Assisted Laparoscopy Combined with Thoracoscopy in the Treatment of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus
Annals of Surgical Oncology·2023· 4 cited
Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study
Frontiers in Immunology·2023· 12 citedOpen Access
Data from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Xiujun Cai(24), Xiao Liang(16), Hui Lin(10), Yuelong Liang(9), Chawnshang Chang(9), Gonghui Li(7), Jie Zhao(5), Jinghua Liu(5), Hong Yu(5), Junjie Xu(5), Yin Sun(5), Wen‐Lung Ma(5), Shuyuan Yeh(5), Junjie Xu(4), Jiang Chen(4), Xiujun Cai(4), Jiasheng Cao(4), Mingyu Chen(4), Xiao‐Dong Zhu(4), Yangxun Pan(4)